Product
AdV-tk
4 clinical trials
8 indications
Indication
Pancreatic adenocarcinomaIndication
Pancreatic CancerIndication
Malignant GliomaIndication
EpendymomaIndication
Glioblastoma MultiformeIndication
Anaplastic AstrocytomaIndication
GliomaIndication
malignantClinical trial
AdV-tk + Valacyclovir Therapy in Combination With Surgery and Chemoradiation for Pancreas CancerStatus: Completed, Estimated PCD: 2013-05-01
Clinical trial
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsStatus: Completed, Estimated PCD: 2015-12-01
Clinical trial
A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant GliomasStatus: Completed, Estimated PCD: 2010-01-01
Clinical trial
Phase I Study of Neoadjuvant GMCI Plus Immune Checkpoint Inhibitor Combined With Standard of Care for Newly Diagnosed High-Grade GliomasStatus: Active (not recruiting), Estimated PCD: 2023-10-30